Ad is loading...
AVASX
Price
$26.34
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

AVASX vs VVIAX

Header iconAVASX vs VVIAX Comparison
Open Charts AVASX vs VVIAXBanner chart's image
American Beacon Large Cap Value Adv
Price$26.34
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AVASX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVASX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVASX is a StrongSell and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. AVASX (3.51B). VVIAX pays higher dividends than AVASX: VVIAX (2.36) vs AVASX (1.39). AVASX was incepted earlier than VVIAX: AVASX (19 years) vs VVIAX (24 years). AVASX is a more actively managed with annual turnover of: 25.00 vs. VVIAX (10.00). AVASX has a lower initial minimum investment than VVIAX: AVASX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. AVASX (23.21). VVIAX return over 5 years is better than : 53.09 vs. AVASX (5.51).
AVASXVVIAXAVASX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years24 years-
Gain YTD20.32919.672103%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets3.51B184B2%
Annual Yield % from dividends1.392.3659%
Returns for 1 year23.2126.0989%
Returns for 3 years-1.3024.77-5%
Returns for 5 years5.5153.0910%
Returns for 10 years-6.38112.26-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics